Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Water and Wastewater
- Agriculture
- Health and Safety
- Monitoring and Testing
- Environmental
- Manufacturing, Other
- Food and Beverage
- Mining
- Automobile & Ground Transport
- Aerospace & Air Transport
- Waste and Recycling
- Air and Climate
- Defense
- Electronics and Computers
- Domestic
- Forestry & Wood
- Household Appliances
- Real Estate
- Oil, Gas & Refineries
- Government
- Energy
- Construction & Construction Materials
Drug Resistance Suppliers & Manufacturers
84 companies found
based inMont-Saint-Guibert, BELGIUM
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution platform is based on the Genio® system, a CE-Mark validated, ...
based inQiaokou District, CHINA
Wuhan Dico Chemical Co., Ltd (Wuhan Dico) was founded in June 2003. Wuhan Dico is a professional enterprise in fine chemical, formulation and possess of many senior chemical application engineers and market managers. In 2011, Wuhan Dico Chemical ...
Effective ingredient of PHMB solution is 20% (weight ratio). It is colorless to light yellow vaporous liquid. Viscosity (25℃) is 5mpas, PH value (25℃) is 4.0-4.5, boiling point is 102℃, density (25℃) is 1.04. Without strong ...
based inBozeman, MONTANA (USA)
Microbion is a clinical-stage pharmaceutical company developing a novel class of compounds for the treatment of difficult-to-treat infections, including chronic infections and antibiotic-resistant infections. Microbion is dedicated to developing ...
Microbion has two Phase 2 clinical programs in diabetic foot ulcer infection and orthopedic implant infection. In addition, preclinical programs are under development for multiple therapeutic indications, including the treatment of serious ...
based inAjman, UNITED ARAB EMIRATES
Chlory was established in 2001. It has a history of 20 years and is committed to the production of products in the field of water disinfection; it specializes in Electro Chlorination Technology, including: electrolytic hypochlorous acid ...
Concentration:10-500ppm. PH: 4.5 -6.5 adjustable, ORP: 1000-1200mV. HOCL Shelf life: 12-24 months. Capacity: Max. 1200L/H. Input: Self-developed raw materials, Electricity, Water. Output: CLEAN HOCL Medical Grade(HCLO, residual Raw Materila ...
based inXiamen City,, CHINA
Found in 1999, Huiying Animal Health Co. Ltd. is located in the beautiful garden city—Xiamen, with subsidiary corporations including Xiamen Huiying Animal Science Tech. Co. Ltd., Xiamen Huiying Animal Pharmaceutical Co. Ltd., Xiamen Jundingxin ...
based inHilden, GERMANY
QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins ...
based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
Work on earlier programmes investigating infections in areas such as respiratory, dermal, ocular and biofilms carries on as research projects, including academic and/or commercial collaborations and grant funded ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
WDR5-0103 is a potent and selective WD repeat-containing protein 5 (WDR5) antagonist with Kd of 450 ...
based inNew York, NEW YORK (USA)
ENB is developing platform oncology molecules to unlock the full therapeutic potential of immune-based cancer therapies. We are developing small molecules that turn off a common “switch” that activates critical pro-cancer components of the TME: the ...
based inOviedo, FLORIDA (USA)
Curis Decontamination specializes in advanced biodecontamination technologies, providing multi-functional systems designed to maintain sterile environments across various industries. Their product lineup includes the CURIS 3 Hybrid Hydrogen ...
based inSalt Lake City, UTAH (USA)
Light Line Medical, Inc.’s patented visible-light platform technology is an infection prevention game-changer, destined to create a massive global shift in how the world prevents and treats healthcare-associated infections. The CDC reported that ...
based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Tulmimetostat is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target coverage through extended on-target residence time. EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a ...
based inBethlehem, PENNSYLVANIA (USA)
Piramal Critical Care (PCC), a business division of Piramal Pharma Limited (PPL) is one of the leaders in inhaled anesthetics and a global player in hospital generics. “Saving and improving patients’ lives” is much more than a purpose statement to ...
These highlights do not include all the information needed to use LINEZOLID INJECTION safely and effectively. See full prescribing information for LINEZOLID ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
based inSouth Melbourne, AUSTRALIA
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Our business model is to generate income from partnerships including with other vaccine and infectious ...
BDM-I: Addressing market need for next-generation antimicrobials. Infectious diseases often dominate the media headlines, including rising antibiotic resistance and fear of “super bugs”. One serious problem facing the ...
based inBellevue, WASHINGTON (USA)
We are solving the problem of unnecessary antibacterial therapy in the treatment of middle ear infections. OtoNexus Medical Technologies´ state-of-the-art advanced ultrasound otoscope analyzes the presence and type of effusion so that primary care ...
based inScoresby, AUSTRALIA
Wintermute Biomedical began with a decade of medical research to find solutions to drug resistant infections. Our scientists found a way to unlock the natural antimicrobial power of fatty acids which are a part of everyday foods. We are a biomedical ...
Antimicrobial Resistance (AMR) is among the greatest global health challenges of our time. AMR occurs when a micro-organism becomes resistant to an antimicrobial medicine, such as an antibiotic. Today, an estimated ...
based inGuangzhou, CHINA
KINGFA was founded in 1993 and listed on the Shanghai Stock Exchange in 2004 (stock code: 600143.SH). It is the world's leading high-tech manufacturing company, committed to R&D, production and marketing of advanced polymer materials, PPE & Medical ...
based inBuffalo, NEW YORK (USA)
We are a medical technology company focused on changing outcomes for patients. We intend to cure all patients with implant biofilm infections by advancing technologies, enhancing the effectiveness of treatments, working alongside the existing ...
Currently under investigation to study the elimination of biofilm infections on prosthetic knee implants during early intervention procedures while maintaining the current standard of ...
based inMountain View, CALIFORNIA (USA)
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and ...
